Kenneth D Bagshawe

Summary

Country: UK

Publications

  1. ncbi Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
    Kenneth D Bagshawe
    Department of Oncology, Royal Free and University College Medical School, University College London, UK
    Expert Opin Biol Ther 4:1777-89. 2004
  2. ncbi Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
    Kenneth D Bagshawe
    Imperial College London, Department of Medical Oncology, Charing Cross Campus, Fulham Palace Road, London W6 8RF, UK
    Expert Rev Anticancer Ther 6:1421-31. 2006
  3. ncbi Trophoblastic reminiscences
    Kenneth D Bagshawe
    Trophoblast Disease Centre, Charing Cross Hospital, London, England
    J Reprod Med 51:849-54. 2006
  4. ncbi History of the International Society for the Study of Trophoblastic Disease
    Kenneth D Bagshawe
    Charing Cross Gestational Trophoblastic Disease Unit, Imperial College School of Medicine, 8L17, 8th Floor, L Block, Charing Cross Campus, London, UK
    J Reprod Med 49:627-9. 2004
  5. ncbi Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblast disease and testicular cancer
    Hugh Mitchell
    Gestational Trophoblastic Disease Centre, Department of Health, Charing Cross Hospital, London, UK
    J Reprod Med 51:868-70. 2006
  6. ncbi I never did become a cardiologist
    Kenneth D Bagshawe
    Department of Medical Oncology, Imperial College School of Medicine, Charing Cross Campus, London W6 8RF, UK
    Lancet 363:1502. 2004
  7. ncbi Advances in antibody-directed enzyme prodrug therapy
    Surinder K Sharma
    Department of Oncology, Royal Free and University College Medical School, University College London, Hampstead Campus, Rowland Hill Street, London NW3 2PF
    Curr Opin Investig Drugs 6:611-5. 2005

Detail Information

Publications7

  1. ncbi Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
    Kenneth D Bagshawe
    Department of Oncology, Royal Free and University College Medical School, University College London, UK
    Expert Opin Biol Ther 4:1777-89. 2004
    ..The relatively small number of purpose-designed prodrugs tested so far leaves this an area ripe for further development. The ongoing iterative process between preclinical and clinical studies is critical to achieving the objective...
  2. ncbi Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
    Kenneth D Bagshawe
    Imperial College London, Department of Medical Oncology, Charing Cross Campus, Fulham Palace Road, London W6 8RF, UK
    Expert Rev Anticancer Ther 6:1421-31. 2006
    ....
  3. ncbi Trophoblastic reminiscences
    Kenneth D Bagshawe
    Trophoblast Disease Centre, Charing Cross Hospital, London, England
    J Reprod Med 51:849-54. 2006
    ..In terms of experience and data collection, the advantages of a specialized service are overwhelming. This society's main thrust should be to ensure that women with GTD in all countries benefit from specialized management...
  4. ncbi History of the International Society for the Study of Trophoblastic Disease
    Kenneth D Bagshawe
    Charing Cross Gestational Trophoblastic Disease Unit, Imperial College School of Medicine, 8L17, 8th Floor, L Block, Charing Cross Campus, London, UK
    J Reprod Med 49:627-9. 2004
  5. ncbi Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblast disease and testicular cancer
    Hugh Mitchell
    Gestational Trophoblastic Disease Centre, Department of Health, Charing Cross Hospital, London, UK
    J Reprod Med 51:868-70. 2006
  6. ncbi I never did become a cardiologist
    Kenneth D Bagshawe
    Department of Medical Oncology, Imperial College School of Medicine, Charing Cross Campus, London W6 8RF, UK
    Lancet 363:1502. 2004
  7. ncbi Advances in antibody-directed enzyme prodrug therapy
    Surinder K Sharma
    Department of Oncology, Royal Free and University College Medical School, University College London, Hampstead Campus, Rowland Hill Street, London NW3 2PF
    Curr Opin Investig Drugs 6:611-5. 2005
    ..Advances in molecular, structural and systems biology, in combination with bioinformatics, have allowed these molecules to be readily manipulated to provide the desired characteristics...